Table 4 Over-represented biological pathways detected within the more highly expressed gene subset identified in somatic embryos
From: Global scale transcriptome analysis of Arabidopsis embryogenesis in vitro
Biological pathway | Probability |
|---|---|
Cell Cycle, Mitotic | 1.10E-39 |
DNA Replication | 2.50E-16 |
Endoreduplication and Alternative cell cycles | 3.30E-13 |
Cell Cycle Checkpoints | 9.30E-05 |
Pyrimidine metabolism (KEGG) | 3.10E-04 |
Purine metabolism (KEGG) | 1.90E-02 |
Cytokinins-O-glucoside biosynthesis (AraCyc) | 2.50E-02 |
Cytokinins 7-N-glucoside biosynthesis (AraCyc) | 2.50E-02 |
Cytokinins 9-N-glucoside biosynthesis (AraCyc) | 2.50E-02 |
Anthocyanin biosynthesis (AraCyc) | 2.60E-02 |
Sucrose Biosynthesis | 2.80E-02 |
Methionine degradation II (AraCyc) | 2.80E-02 |
G1/S DNA integrity checkpoint | 2.80E-02 |
Glucosinolate biosynthesis from homomethionine (AraCyc) | 4.10E-02 |
Diterpenoid biosynthesis (KEGG) | 4.90E-02 |
de novo biosynthesis of purine nucleotides II (AraCyc) | 5.40E-02 |
Glucosinolate biosynthesis from tryptophan (AraCyc) | 6.30E-02 |
Glucosinolate biosynthesis from phenylalanine (AraCyc) | 6.90E-02 |
Sucrose degradation to ethanol and lactate (anaerobic) (AraCyc) | 7.70E-02 |
Sucrose biosynthesis (AraCyc) | 8.30E-02 |
Gibberellin biosynthesis III (early C-13 hydroxylation) (AraCyc) | 9.10E-02 |